Cargando…
P707: MUTATIONS IN THE COHESIN GENE STAG2 ARE ASSOCIATED WITH REDUCED INFLAMMATORY GENEEXPRESSION AND AN INCREASE IN HEMATOPOIETIC STEM CELL POPULATIONS IN MYELODYSPLASTICSYNDROME PATIENTS
Autores principales: | Ashish Bhattacharya, Shubhra, Sakuma, Maki, Walter, Wencke, Haferlach, Torsten, Malinverni, Roberto, Buschbeck, Marcus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428991/ http://dx.doi.org/10.1097/01.HS9.0000969732.67131.fc |
Ejemplares similares
-
Different NIPBL requirements of cohesin-STAG1 and cohesin-STAG2
por: Alonso-Gil, Dácil, et al.
Publicado: (2023) -
The consequences of cohesin mutations in myeloid malignancies
por: Bhattacharya, Shubhra Ashish, et al.
Publicado: (2023) -
STAG1 vulnerabilities for exploiting cohesin synthetic lethality in STAG2-deficient cancers
por: van der Lelij, Petra, et al.
Publicado: (2020) -
Synthetic lethality between the cohesin subunits STAG1 and STAG2 in diverse cancer contexts
por: van der Lelij, Petra, et al.
Publicado: (2017) -
Loss of cohesin complex components STAG2 or STAG3 confers resistance to BRAF inhibition in melanoma
por: Shen, Che-Hung, et al.
Publicado: (2016)